PMID- 32132963 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200928 IS - 1664-2295 (Print) IS - 1664-2295 (Electronic) IS - 1664-2295 (Linking) VI - 11 DP - 2020 TI - Two Cases of Late-Onset Anti-NMDAr Auto-Immune Encephalitis After Herpes Simplex Virus 1 Encephalitis. PG - 38 LID - 10.3389/fneur.2020.00038 [doi] LID - 38 AB - Context: Encephalitis due to herpes simplex virus 1 (HSV-1) was described as a potential trigger for the development of anti-N-methyl-D-aspartate receptor (NMDAr) auto-immune encephalitis (AIE) within a few days to a few weeks after the infection. Methods: We assessed clinical, radiological, and biological diagnoses process, treatment response, and evolution. Cases Reported: We report here cases of a 71-year-old man and a 57-year-old woman presenting anti-NMDAr AIE, respectively, 12 and 7 months after HSV-1 encephalitis. In both cases, the onset was brisk, and the symptoms were mainly neuropsychiatric (paranoid delirium, Capgras, and Cotard syndromes) and cognitive, with anterograde amnesia. Relapse of HSV encephalitis, epilepsy, and paraneoplastic neurologic syndromes were excluded. The clinical response to first-line treatments composed of intravenous immunoglobulins and high-dose corticosteroids was poor, whereas significant improvement was noticed after rituximab induction. Conclusion: Post-herpetic anti-NMDAr AIE could arise several months after infection. Clinicians must be aware of this possibility, particularly if cognitive and/or psychiatric symptoms occurred after a remitting period. In our two cases, only rituximab was associated with clinical improvement. CI - Copyright (c) 2020 Dorcet, Benaiteau, Bost, Mengelle, Bonneville, Martin-Blondel and Pariente. FAU - Dorcet, Guillaume AU - Dorcet G AD - Departement de Neurologie, Hopital Pierre Paul Riquet, CHU de Toulouse, Toulouse, France. FAU - Benaiteau, Marie AU - Benaiteau M AD - Departement de Neurologie, Hopital Pierre Paul Riquet, CHU de Toulouse, Toulouse, France. FAU - Bost, Chloe AU - Bost C AD - Laboratoire d'Immunologie, Institut Federatif de Biologie, CHU de Toulouse, Toulouse, France. AD - INSERM U1043 - CNRS UMR 5282, Centre de Physiopathologie Toulouse-Purpan, Toulouse, France. FAU - Mengelle, Catherine AU - Mengelle C AD - Laboratoire de Virologie, Institut Federatif de Biologie, CHU de Toulouse, Toulouse, France. FAU - Bonneville, Fabrice AU - Bonneville F AD - Service de Neuroradiologie, Hopital Pierre Paul Riquet, CHU de Toulouse, Toulouse, France. AD - INSERM: ToNIC, Toulouse NeuroImaging Center, Universite de Toulouse, Inserm, Universite Paul Sabatier, Toulouse, France. FAU - Martin-Blondel, Guillaume AU - Martin-Blondel G AD - INSERM U1043 - CNRS UMR 5282, Centre de Physiopathologie Toulouse-Purpan, Toulouse, France. AD - Service de Maladies Infectieuses et Transmissibles, Batiment Urgences Reanimation Medecine, CHU de Toulouse, Toulouse, France. FAU - Pariente, Jeremie AU - Pariente J AD - Departement de Neurologie, Hopital Pierre Paul Riquet, CHU de Toulouse, Toulouse, France. AD - INSERM: ToNIC, Toulouse NeuroImaging Center, Universite de Toulouse, Inserm, Universite Paul Sabatier, Toulouse, France. LA - eng PT - Case Reports DEP - 20200218 PL - Switzerland TA - Front Neurol JT - Frontiers in neurology JID - 101546899 PMC - PMC7040193 OTO - NOTNLM OT - anti-NMDA antibodies OT - autoimmune encephalitis OT - cerebrospinal fluid OT - herpes simplex OT - herpetic meningoencephalitis EDAT- 2020/03/07 06:00 MHDA- 2020/03/07 06:01 PMCR- 2020/02/18 CRDT- 2020/03/06 06:00 PHST- 2019/08/30 00:00 [received] PHST- 2020/01/10 00:00 [accepted] PHST- 2020/03/06 06:00 [entrez] PHST- 2020/03/07 06:00 [pubmed] PHST- 2020/03/07 06:01 [medline] PHST- 2020/02/18 00:00 [pmc-release] AID - 10.3389/fneur.2020.00038 [doi] PST - epublish SO - Front Neurol. 2020 Feb 18;11:38. doi: 10.3389/fneur.2020.00038. eCollection 2020.